Formulation and evaluation of lactoferrin bioadhesive tablets

International Journal of Pharmaceutics

Volumn 343, Issue 1-2, 2007, Pages 220-227

  Takahashi, Y ^a   Takeda, C ^a   Seto, I ^b   Kawano, G ^b   Machida, Y ^a  

^a HOSHI UNIVERSITY   (Japan)

^b NRL Pharma Inc   (Japan)

Author keywords

Bioadhesive tablets; Chronic inflammation; Lactoferrin; Oral mucosa; Pectin; Xylitol

Indexed keywords

CARBOXYMETHYLCELLULOSE; EMULSIFYING AGENT; LACTOFERRIN; PECTIN; TAMARIND GUM; UNCLASSIFIED DRUG; XYLITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG SCREENING; DRUG SYNTHESIS; IMMUNOREGULATION; MALE; MOUTH CAVITY; MOUTH INFLAMMATION; MOUTH MUCOSA; MOUTH ULCER; NONHUMAN; PRIORITY JOURNAL; RAT; TABLET; TABLET COMPRESSION; TASTE;

ABSORPTION; ADHESIVES; ADMINISTRATION, BUCCAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; HUMANS; LACTOFERRIN; MALE; MICE; MICE, INBRED STRAINS; MOUTH MUCOSA; ORAL ULCER; PARTICLE SIZE; PECTINS; RATS; RATS, SPRAGUE-DAWLEY; TABLETS; TENSILE STRENGTH; WATER;

EID: 34548285501     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.05.032     Document Type: Article

References (24)

1. Arnold R.R., Brewer M., and Gauthier J.J. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun. 28 (1980) 893-898
2. Arnold R.R., Cole M.F., and McGhee J.R. A bactericidal effect for human lactoferrin. Science 197 (1977) 263-265
3. Arnold R.R., Russell J.E., Champion W.J., and Gauthier J.J. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect. Immun. 32 (1981) 655-660
4. Bullen J.J., Rogers H.J., and Griffiths E. Role of iron in bacterial infection. Curr. Top. Microbiol. Immunol. 80 (1978) 1-35
5. Choi H., Jung J., Yong C.S., Rhee C., Lee M., Han J., Park K., and Kim C. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J. Control. Release 68 (2000) 405-412
6. Crouch S.P., Slater K.J., and Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80 (1992) 235-240
7. Cumberbatch M., Dearman R.J., Uribe-Luna S., Headon D.R., Ward P.P., Conneely O.M., and Kimber I. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 100 (2000) 21-28
8. Duncan M., and Grant G. Oral and intestinal mucositis-causes and possible treatments. Aliment. Pharmacol. Ther. 18 (2003) 853-874
9. Ellison R.T.D., Giehl T.J., and LaForce F.M. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56 (1988) 2774-2781
10. Fell J.T., and Newton J.M. Determination of tablet strength by the diametral compression test. J. Pharm. Sci. 59 (1970) 688-691
11. Ishida M., Machida Y., Nambu N., and Nagai T. New mucosal dosage form of insulin. Chem. Pharm. Bull. 29 (1981) 810-816
12. Machida Y., Masuda H., Fujiyama N., Ito S., Iwata M., and Nagai T. Preparation and phase II clinical examination of topical dosage form for treatment of carcinoma coli containing bleomycin with hydroxypropyl cellulose. Chem. Pharm. Bull. 27 (1979) 93-100
13. Machnicki M., Zimecki M., and Zagulski T. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74 (1993) 433-439
14. Masson P.L., and Heremans J.F. Lactoferrin in milk from different species. Comp. Biochem. Physiol. B 39 (1971) 119-129
15. Masson P.L., Heremans J.F., and Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130 (1969) 643-658
16. Nakamura F., Ohta R., Machida Y., and Nagai T. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int. J. Pharm. 134 (1996) 173-181
17. Pentecost B.T., and Teng C.T. Lactotransferrin is the major estrogen inducible protein of mouse uterine secretions. J. Biol. Chem. 262 (1987) 10134-10139
18. Rabiller-Baudry M., and Chaufer B. Specific adsorption of phosphate ions on proteins evidenced by capillary electrophoresis and reversed-phase high-performance liquid chromatography. J. Chromatogr. B 753 (2001) 67-77
19. Sato R., Inanami O., Tanaka Y., Takase M., and Naito Y. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats. Am. J. Vet. Res. 57 (1996) 1443-1446
20. Satoh K., Takayama K., Machida Y., Suzuki Y., Nakagaki M., and Nagai T. Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. Chem. Pharm. Bull. 37 (1989) 1366-1368
21. Slomiany B.L., Piotrowski J., and Slomiany A. Suppression of caspase-3 and nitric oxide synthase-2 during buccal mucosal ulcer healing: effect of chronic alcohol ingestion. IUBMB Life 48 (1999) 121-125
22. Slomiany B.L., and Slomiany A. Activation of peroxisome proliferator-activated receptor gamma suppresses inducible cyclooxygenase and nitric oxide synthase during oral mucosal ulcer healing. J. Physiol. Pharmacol. 53 (2002) 159-169
23. Szpaderska A.M., Zuckerman J.D., and DiPietro L.A. Differential injury responses in oral mucosal and cutaneous wounds. J. Dent. Res. 82 (2003) 621-626
24. Yu L.C., and Chen Y.H. The developmental profile of lactoferrin in mouse epididymis. Biochem. J. 296 (1993) 107-111